ArticleNPJ precision oncology2026

Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis.

Yasuyoshi Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.